IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C von Bochud, P.-Y, Bibert, S, Negro, F, Haagmans, B, Soulier, A, Ferrari, C, Missale, G, Zeuzem, S, Pawlotsky, J.-M, Schalm, S, Hellstrand, K, Neumann, A.U, Lagging, M

Volltext

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia von Bernson, E, Hallner, A, Sander, F E, Wilsson, O, Werlenius, O, Rydström, A, Kiffin, R, Brune, M, Foà, R, Aurelius, J, Martner, A, Hellstrand, K, Thorén, F B

Volltext

Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda von Mukanyangezi, MF, Rugwizangoga, B, Manzi, O, Rulisa, S, Hellstrand, K, Tobin, G, Martner, A, Bienvenu, E, Giglio, D

Volltext

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1 von Lindh, M., Lagging, M., Arnholm, B., Eilard, A., Nilsson, S., Norkrans, G., Söderholm, J., Wahlberg, T., Wejstål, R., Westin, J., Hellstrand, K.

Volltext

Inosine triphosphate pyrophosphatase enhances the effect of ribavirin on hepatitis C virus cell culture infection von Nyström, K, Pettersson, G, Wanrooij, P.H, Brunet, S, Said, J, Ortolani, G, Waldenström, J, Adamek, L, Tang, K.-W, Norberg, P, Chabes, A, Hellstrand, K, Norder, H, Lagging, M

Volltext

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection von Westin, J., Lagging, M., Dhillon, A. P., Norkrans, G., Romero, A. I., Pawlotsky, J.-M., Zeuzem, S., Schalm, S. W., Verheij-Hart, E., Negro, F., Missale, G., Neumann, A. U., Hellstrand, K.

Volltext

Post‐consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin‐2 in AML von Romero, A. I., Thorén, F. B., Aurelius, J., Askarieh, G., Brune, M., Hellstrand, K.

Volltext

Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine von Mellqvist, Ulf-Henrik, Hansson, Markus, Brune, Mats, Dahlgren, Claes, Hermodsson, Svante, Hellstrand, Kristoffer

Volltext

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Mela... von Agarwala, S. S.

Volltext

A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis von Betten A, Bylund, J, Christophe, T, Cristophe, T, Boulay, F, Romero, A, Hellstrand, K, Dahlgren, C

Volltext

Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection von Alsiö, Å., Jannesson, A., Langeland, N., Pedersen, C., Färkkilä, M., Buhl, M. R., Mørch, K., Westin, J., Hellstrand, K., Norkrans, G., Lagging, M.

Volltext

Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon- alpha 2b and histamine dihydrochloride versu... von Middleton, M, Hauschild, A, Thomson, D, Anderson, R, Burdette-Radoux, S, Gehlsen, K, Hellstrand, K, Naredi, P

Volltext

Are FoxP3+ cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? von Westin, J., Hellstrand, K., Dhillon, A. P., Lagging, M.

Volltext

Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin von Lindh, M., Arnholm, B., Björkman, P., Hellstrand, K., Lagging, M., Nilsson, S., Wahlberg, T., Wallmark, E., Weiland, O., Wejstål, R., Westin, J., Widell, A., Norkrans, G.

Volltext

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation von Einarsdottir, Sigrun, Martner, Anna, Nicklasson, Malin, Wiktorin, Hanna Grauers, Arabpour, Mohammad, Törnell, Andreas, Vaht, Krista, Waldenström, Jesper, Ringlander, Johan, Bergström, Tomas, Brune, Mats, Hellstrand, Kristoffer, Ljungman, Per, Lagging, Martin

Volltext

Hepatitis C treatment response kinetics and impact of baseline predictors von Lindh, M., Arnholm, B., Eilard, A., Färkkilä, M., Hellstrand, K., Lagging, M., Langeland, N., Mørch, K., Nilsson, S., Pedersen, C., Buhl, M. R., Wahlberg, T., Wejstål, R., Westin, J., Norkrans, G.

Volltext

Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia – background and results von Brune, M., Romero, A. I., Hellstrand, K.

Volltext

Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites von Hellstrand, K, Asea, A, Dahlgren, C, Hermodsson, S

Volltext

PO27-TH-06 Oxygen radical production in the recurrent Guillain–Barré syndrome von Mossberg, N, Andersen, O, Hellstrand, K, Bergström, T, Movitz, C

Volltext

Wider indications for treatment of chronic hepatitis B? von Lindh, M., Hellstrand, K., Norkrans, G.

Volltext